Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,335 | 3 | 63.6% |
| Food and Beverage | $2,434 | 23 | 35.7% |
| Travel and Lodging | $33.79 | 1 | 0.5% |
| Education | $8.62 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $5,110 | 12 | $0 (2022) |
| Amgen Inc. | $562.16 | 6 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $422.80 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $177.36 | 2 | $0 (2019) |
| GENZYME CORPORATION | $121.32 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $115.42 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $110.00 | 1 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $109.48 | 1 | $0 (2024) |
| Alkermes, Inc. | $83.29 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.48 | 1 | JAZZ PHARMACEUTICALS INC. ($109.48) |
| 2023 | $184.62 | 1 | E.R. Squibb & Sons, L.L.C. ($184.62) |
| 2022 | $391.65 | 4 | Novo Nordisk Inc ($198.36) |
| 2021 | $2,161 | 3 | Novo Nordisk Inc ($2,040) |
| 2019 | $518.12 | 5 | Amgen Inc. ($348.14) |
| 2018 | $2,931 | 8 | Novo Nordisk Inc ($2,590) |
| 2017 | $515.44 | 6 | Novo Nordisk Inc ($221.26) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/24/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $109.48 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/02/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $184.62 | General |
| 03/23/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $73.36 | General |
| Category: Diabetes | ||||||
| 03/22/2022 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $83.29 | General |
| Category: CNS | ||||||
| 03/08/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 02/24/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: ONCOLOGY | ||||||
| 11/29/2021 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $121.32 | General |
| Category: Oncology | ||||||
| 04/29/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Consulting Fee | Cash or cash equivalent | $1,020.00 | General |
| Category: Diabetes | ||||||
| 04/28/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Consulting Fee | Cash or cash equivalent | $1,020.00 | General |
| Category: Diabetes | ||||||
| 08/22/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $109.95 | General |
| 06/04/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $109.73 | General |
| Category: Bone Health | ||||||
| 05/23/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 05/01/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $60.03 | General |
| Category: Diabetes | ||||||
| 02/26/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $113.41 | General |
| Category: Bone Health | ||||||
| 11/29/2018 | Novo Nordisk Inc | Victoza (Drug) | Consulting Fee | Cash or cash equivalent | $2,295.00 | General |
| Category: Diabetes | ||||||
| 11/29/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $122.07 | General |
| Category: Diabetes | ||||||
| 11/29/2018 | Novo Nordisk Inc | Victoza (Drug) | Travel and Lodging | In-kind items and services | $33.79 | General |
| Category: Diabetes | ||||||
| 11/13/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $104.31 | General |
| Category: Neuroscience | ||||||
| 09/18/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $76.13 | General |
| Category: Diabetes | ||||||
| 08/10/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $121.12 | General |
| 04/26/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $63.30 | General |
| Category: Diabetes | ||||||
| 04/18/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $115.42 | General |
| 06/13/2017 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $117.06 | General |
| 06/07/2017 | Amgen Inc. | — | Education | In-kind items and services | $8.62 | General |
| 06/06/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $101.09 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 136 | 180 | $41,709 | $11,633 |
| 2022 | 5 | 234 | 303 | $73,825 | $19,117 |
| 2021 | 8 | 359 | 463 | $112,881 | $31,881 |
| 2020 | 10 | 521 | 652 | $134,110 | $35,381 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 19 | 19 | $5,168 | $1,599 | 30.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 43 | 44 | $7,568 | $1,293 | 17.1% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 15 | 15 | $2,370 | $408.80 | 17.2% |
About Dr. Lynn Bowlby, MD
Dr. Lynn Bowlby, MD is a Internal Medicine healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588611123.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lynn Bowlby, MD has received a total of $6,812 in payments from pharmaceutical and medical device companies, with $109.48 received in 2024. These payments were reported across 28 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($4,335).
As a Medicare-enrolled provider, Bowlby has provided services to 1,250 Medicare beneficiaries, totaling 1,598 services with total Medicare billing of $98,012. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Providence, RI
- Active Since 05/28/2006
- Last Updated 11/20/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588611123
Products in Payments
- Victoza (Drug) $2,578
- RYBELSUS (Drug) $2,040
- EVENITY (Biological) $234.73
- LIBTAYO (Biological) $231.32
- Prolia (Biological) $214.50
- Ozempic (Drug) $196.69
- Tresiba (Drug) $170.72
- Rybelsus (Drug) $125.00
- ZEPZELCA (Drug) $109.48
- Aimovig (Biological) $104.31
- VIVITROL (Drug) $83.29
- JARDIANCE (Drug) $67.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Providence
Randall Ingham, M.d, M.D
Internal Medicine — Payments: $154,470
Farah Moustafa, Md, MD
Internal Medicine — Payments: $50,984
Monica Dhakar, M.d, M.D
Internal Medicine — Payments: $47,405
Hajra Awwab, Md, MD
Internal Medicine — Payments: $41,418
Richard Ruggieri, M.d, M.D
Internal Medicine — Payments: $36,352
Dr. Peter Barth, M.d, M.D
Internal Medicine — Payments: $29,192